Lipids, Lipoproteins and Aging Trudy M. Forte, Ph.D. Life Sciences Division

26
Lipids, Lipoproteins and Aging Trudy M. Forte, Ph.D. Life Sciences Division Lawrence Berkeley National Lab

description

Lipids, Lipoproteins and Aging Trudy M. Forte, Ph.D. Life Sciences Division Lawrence Berkeley National Lab. Early and late atherosclerotic lesions. Fatty streak. Thrombotic athero lesion, myocardial infarct. Generic Lipoprotein. - PowerPoint PPT Presentation

Transcript of Lipids, Lipoproteins and Aging Trudy M. Forte, Ph.D. Life Sciences Division

Page 1: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Lipids, Lipoproteins and Aging

Trudy M. Forte, Ph.D. Life Sciences Division

Lawrence Berkeley National Lab

Page 2: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Fatty streak

Thrombotic athero lesion, myocardial infarct

Early and late atherosclerotic lesions

Page 3: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Generic Lipoprotein

Page 4: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Role of Lipids (Lipoproteins) in Metabolism

Triglycerides Major energy source for cells

Cholesterol Cell growth, cell division, membranerepair, steroid hormone production

Lipids Transport of fat soluble vitamins

Page 5: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Normal Plasma Lipid Levels (mg/dl)

Triglyceride Total Chol. HDL-Chol TC/HDLC

Adult female 80 190 55 3.5

Adult male 120 200 43 4.7

Neonate 35 70 35 2.0

Page 6: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Positive and Negative risk Factors in Atherosclerosis

Positive Negative

Age: Males > 45 years Elevated HDL cholesterol

Females > 55 years Low LDL cholesterol

Family history of early CHD Good genes

Elevated LDL cholesterol (>130 mg/dl) Female gender (estrogen)

Diabetes mellitus Excerise

Hypertension

Obesity

Smoking

CHD, coronary heart disease

Page 7: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

CM VLDL IDL LDL HDL

Lipoprotein Nomenclature and Composition

Major apoB apoB apoB apoB apoA-IProtein

Major TG TG CE CE CELipid

CM= chylomicron TG=triglycerideVLDL= very low density lipoprotein CE= cholesteryl esterIDL= intermediate density lipoproteinLDL= low density lipoproteinHDL= high density lipoproteinApo = apolipoprotein

Page 8: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Nascent-HDLapoA-I

Liver

VLDL

apoB-100

apoCs

apoE

IDL LDL

apoB-100apoE

apoB-100

apoB-48

CM

apoCs

Intestine

Nascent-HDLapoA-I

Site of Synthesis of Lipoproteins

Page 9: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Major Apolipoproteins and Their Function

Apo Lipo Origin Function

ApoA-I HDL Liver, intestine Activate LCAT, Cholesterol efflux via ABCA1 transporter

ApoB-100 VLDL, Liver, intestine Ligand LDL receptor, TG LDL transport from cells

Apo(a) Lp(a) Liver Inhibits thrombolysis

ApoCII HDL, VLDL Liver Activates lipoprotein lipase

ApoE VLDL, IDL Liver, intestine Ligand, LDL receptor, LRP receptor

LCAT: lecithin:cholesterol acyltransferaseABCA1: ATP binding cassette protein A1LRP: LDL receptor related protein

Page 10: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Structure of Lp(a)

LDL

NC

S S

C

apo(a)

apoB-100

4

4

4

4

5

Kringle

N

Page 11: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Apo E Isoforms

Apo E3 most common, normal isoforma.a. 112 cys

a.a. 158 arg

Apo E2 hypercholesteremia, inadequate clearance of remnantsa.a. 112 cys

a.a. 158 cys

Apo E4 elevated triglyceride; Alzheimers diseasea.a. 112 arg

a.a. 158 arg

Page 12: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Alzheimer’s disease and Lipoproteins

Early onset AD, prior to age 60:• mutation in amyloid precursor protein gene, chr 21

• unidentified gene, chr 14

Late onset AD involves chr 19:• apo E gene on chr 19

• association of AD with apo E4 allele

• 80% of familial AD have at least one apo E4 allele

• apo E4 a major risk factor in AD

Page 13: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Key Enzymes in Lipoprotein Metabolism

• Lipoprotein lipase (LPL): hydrolysis of triglyceride rich particles

• Lecithin:cholesterol acyltransferase (LCAT): participates in removal of excess cholesterol from peripheral cells

Page 14: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Lipoprotein Lipase (LPL)

LPL

Excess SurfaceMaterial

HDL assembly

Fatty Acidsand

Glycerol

Energy

apoC-II

CM

VLDLapoE

apoA-I

cholesterol

phospholipid

Endothelial Cell

CM

VLDLapoE

Liver

Lipolyticproducts

Bile acids

muscle

“Remnant”

TG

TG = triglyceride

LDL

Page 15: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

LCAT

Phospholipid plus cholesterol

Nascent HDL

LCAT: Disk to sphere transformation

Mature HDL

Cholesteryl ester (CE)plus lysophospholipid

apoA-ICE

Cholesteryl ester (CE)

Cholesterol

Phospholipid

ApoA-I

Lecithin:Cholesterol Acyl Transferase (LCAT)

Free cholesterol Cholesteryl ester

Page 16: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Key Receptors in Lipoprotein Metabolism

• LDL receptor: catabolism of LDL, apoB ligand

• ABCA1 transporter: transports excess cholesterol from cells, apoA-I ligand

• Scavenger receptor A1 (SR-A1): uptake of oxidized and modified LDL by macrophages

• SR-B1 receptor:selective uptake of excess cholesterol from HDL, apoA-I ligand

Page 17: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

LDL-Receptors

Endosome Lysosome

Aminoacids

CholesterolLDL

Cholesteryl ester(storage)LDL

Receptors

HMG-CoAreductase

LDL

LDL Receptor (apoB-E receptor)

ACAT

Regulates cholesterol synthesis and plasma cholesterol levels

Page 18: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

ABCA1 Transporter/Receptor

Large plasma membrane spanning ATP dependent protein.

Essential for moving excess intracellular cholesterol and phospholipid to the plasma membrane.

Acts as a flipase, flipping cholesterol and phospholipid from inner leaflet of plasma membrane to outer leaflet.

Necessary for removing excess cholesterol from foam cells and preventing early steps in atherosclerosis.

ApoA-I is required for capturing the cholesterol released from the foam cell.

Page 19: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

ABCA1 Function

apoA-INascent HDL

Page 20: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Reverse Cholesterol Transport (RCT)

The process whereby excess cholesterol in peripheral cells, especially foam cells, is returned to the liver for degradation and excretion.

RCT involves apoA-I, ABCA1 and LCAT as well as receptors on the liver for uptake of the excess cholesterol.

Page 21: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Reverse Cholesterol TransportDelivery of peripheral tissue cholesterol to the liver for catabolism

Requires HDL, apoA-I and LCAT

Peripheral Cell UC HDL

HDLCE

HDLUC

ABCA1

LiverVLDLor LDL apoB LDLr

SR-B1

UC

PL

CE

TG

diffusion

LCAT

LCAT

CE

CE

apoA-I

UC = unesterified cholesterolCE = esterified cholesterolPL = phospholipidLDLr = LDL receptor

NascentHDL

Bile to gut

Macrophage/ Foam cell

Page 22: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

The Scavenger Receptor

(SR-A1 receptor)

How macrophages deal with oxidized or modified LDL

The scavenger receptor recognizes modified and/or oxidized LDL and internalizes the modified LDL.

Accumulation of these modified LDL in the cell leads to the accumulation of cholesterol droplets in the macrophage and the formation of foam cells.

Page 23: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

Modification of LDL

LDL

Apo B-100

Derivatization:AldehydesGlucosylationeg. diabetes

Oxidation:Degradation of B-100 by reactiveoxygen species

Derivatized LDL

Oxidized LDL

Page 24: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

The Scavenger Receptor:Clearance of modified LDL by macrophages

Oxidized LDLScavengerreceptor

Macrophage Macrophage Foam Cell

Fatty streaks

Lipid droplets

(SR-A1)

Page 25: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

LDL and AtherosclerosisFitting the pieces together

Elevated LDL: Increased residence time in plasma Increased modification/oxidation of LDL

Artery wall

Monocyte

Endothelialcells

oxLDL

oxLDL (stimulates cytokine secretion)

Macrophage

Macrophage foam cell

Cytokines

Cytokines

Smooth muscle cellproliferation

Page 26: Lipids, Lipoproteins and Aging           Trudy M. Forte, Ph.D.        Life Sciences Division

HDL Protective RoleFitting the pieces together

oxLDL = oxidized LDLUC = unesterified cholesterol

ABCA1apoA-I

Endothelialcells

HDL

HDL

UC

PL

UC

Nascent HDL

HDL + UC

Macrophage foam cell

oxLDL

Monocyte

Arterywall